A very common medical condition globally, sleep apnea is a disorder that interrupts breathing during sleep. Several factors can cause it, though the risk rises sharply with obesity because extra fat ...

People with obesity who received the weight-loss drug Zepbound had fewer obstructive sleep apnea events, or episodes of stopped breathing during sleep. The research by drug maker Eli Lilly included ...

Lauren Pastrana is the co-anchor of CBS4 News weeknights at 5, 6, 7 and 11 p.m. She joined CBS Miami in April 2012 as a reporter. She is an Emmy-nominated, multimedia journalist with experience in ...

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone calls earlier this year after the Food and Drug Administration approved ...

Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep. The ...

By Hugo Francisco de Souza New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing ...

Sleep apnea is a condition that causes breathing to stop and start repeatedly while sleeping. It may occur up to 400 times per night, with each pause lasting 10 seconds or longer. There are two main ...

Continuous positive airway pressure (CPAP) is the standard treatment for treating obstructive sleep apnea (OSA), but clinicians should remember that weight loss is also an effective approach for ...

Weight loss pills and injections are often touted as miracle drugs. Research shows that they can help you lose weight, better help you manage type II diabetes, and even reduce your risk of heart ...

SAN DIEGO, Jan. 22, 2026 /PRNewswire/ -- Lofta, a leading provider of direct-to-consumer sleep apnea care, today announced a strategic alliance with Accomplish Health, a leading virtual obesity and ...